SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2

2025-03-12 REL PDBj INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY EXPERIMENTAL_SUMMARY em_admin pdbx_database_related _em_admin.last_update _pdbx_database_related.content_type OTHER pdbx_database_status _pdbx_database_status.pdb_format_compatible STRUCTURE_SUMMARY chem_comp_atom chem_comp_bond em_admin pdbx_entry_details pdbx_modification_feature _em_admin.last_update _pdbx_entry_details.has_protein_modification DATABASE_REFERENCES em_admin pdbx_database_related _em_admin.last_update _pdbx_database_related.content_type PDBj PDBj 2022-07-05 2022-08-24 2022-08-24 2025-03-12 Other government 82041014 China SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 Liu B Gao X Li Z Chen X He J Chen L Xiong X ACE2, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX He P Liu B Gao X Yan Q Pei R Sun J Chen Q Hou R Li Z Zhang Y Zhao J Sun H Feng B Wang Q Yi H Hu P Li P Zhang Y Chen Z Niu X Zhong X Jin L Liu X Qu K Ciazynska KA Carter AP Briggs JAG Chen J Liu J Chen X He J Chen L Xiong X SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope. Nat Microbiol UK 7 1635 1649 2022 36151403 doi:10.1038/s41564-022-01235-4 2058-5276 EMD-33748 other EM volume 7yeg FULLOVERLAP SARS-COV-2 Spike_GSAS_6P bound with three R1-32 Fabs and three ACE2 SARS-COV-2 Spike_GSAS_6P bound with three R1-32 Fabs and three ACE2 0 1 2 3 4 Severe acute respiratory syndrome coronavirus 2 SARS-COV-2 Spike_GSAS_6P 1 1 Homo sapiens ACE2 1 2 Homo sapiens Fabs 1 3 4 Spike glycoprotein Severe acute respiratory syndrome coronavirus 2 0.13378131199999999 3 Homo sapiens LEVO MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFD NPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVY SSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRV QPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSF VIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFL PFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGS NVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPGSASSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGF NFSQILPDPSKPSKRSPIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAG TITSGWTFGAGPALQIPFPMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTPSALGKLQDVVNQNAQALN TLVKQLSSNFGAISSVLNDILSRLDPPEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRV DFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNT FVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL QELGKYEQ P0DTC2 Angiotensin-converting enzyme 2 Homo sapiens 0.069153664 3 Homo sapiens LEVO STIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQ ALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRP LYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISP IGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGN VQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHL KSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYC DPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKN MNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYAD Q9BYF1 3.4.17.23 heavy chain of R1-32 Fab Homo sapiens 0.023840717 3 Homo sapiens LEVO EVQLVESGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPILGIANYAQKFQGRVTITADKSTSTAY MELSSLRSEDTAVYYCARENGYSGYGAAANFDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEP VTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD light chain of R1-32 Fab Homo sapiens 0.022382643 3 Homo sapiens LEVO QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGL QAEDEADYYCQSYDSSLSGSVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPV KAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT 2-acetamido-2-deoxy-beta-D-glucopyranose 0.000221208 36 NAG ZINC ION 6.5409e-05 3 ZN singleParticle particle 8.0 ETHANE FEI TALOS ARCTICA FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 200 0.8 2.5 45000.0 NITROGEN GATAN K3 (6k x 4k) 6989 1.6 63.0 1 619803 EMD-11333 3.73 FSC 0.143 CUT-OFF 203698 MAXIMUM LIKELIHOOD RELION 3.1 MAXIMUM LIKELIHOOD RELION 3.1 emd_33772.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 300 300 300 0 0 0 300 300 300 422.4 422.4 422.4 90.0 90.0 90.0 X Y Z -0.123639725 0.2323329 0.000044769833 0.004516223 1.408 1.408 1.408 0.02 AUTHOR ::::EMDATABANK.org::::EMD-33772:::: emd_33772_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 300 300 300 0 0 0 300 300 300 422.4 422.4 422.4 90.0 90.0 90.0 X Y Z -0.018914446 0.081008375 0.00004280083 0.0025593794 1.408 1.408 1.408 AUTHOR ::::EMDATABANK.org::::EMD-33772:::: emd_33772_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 300 300 300 0 0 0 300 300 300 422.4 422.4 422.4 90.0 90.0 90.0 X Y Z -0.02091819 0.083605886 0.000041951058 0.002555743 1.408 1.408 1.408 AUTHOR ::::EMDATABANK.org::::EMD-33772::::